Aclaris Therapeutics, Inc. [ACRS] has reported $31.2 million in revenue for year ended Dec 31, 2023.
Also Read: Aclaris: Q1 Earnings Snapshot
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $88.5 million.
Also Read: Aclaris: Q4 Earnings Snapshot
Based in Wayne, Pennsylvania, Aclaris Therapeutics, Inc. operates in the Manufacturing sector.
Related Articles: Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in ... Aclaris Therapeutics Announces Key Leadership Transitions Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
USInMinutes/IndiaInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to more news alerts here. Although care is taken to ensure accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications